Table 3. Effect of the GC test result on urologists treatment recommendations post radical prostatectomy.
Treatment Recommendation | Adjuvant | Salvage | |||||
---|---|---|---|---|---|---|---|
Pre-GC | Post-GC | Pre-GC | Change N (%) | 95% CI | Pre-GC | Change N (%) | 95% CI |
Overall | Any Change | 240 | 103 (43%) | 37-49% | 180 | 95 (53%) | 45-60% |
Observation | Any Treatment | 114 | 42 (37%) | 28-46% | 31 | 19 (61%) | 42-78% |
Radiation | 114 | 37 (32%) | 24-42% | 31 | 12 (39%) | 22-58% | |
Hormone therapy | 114 | 4 (4%) | 1-9% | 31 | 0 (0%) | ||
Radiation + Hormone therapy | 114 | 1 (0.9%) | 0-5% | 31 | 7 (23%) | 10-41% | |
Other* | 114 | 1 (1%) | 0-5% | 31 | 2 (7%) | 0.8-21% | |
Any Treatment | Observation | 125 | 34 (27%) | 19-35% | 143 | 23 (16%) | 11-23% |
Radiation | Observation | 100 | 31 (31%) | 22-41% | 82 | 11 (13%) | 7-23% |
Hormone therapy | Observation | 1 | 1 (100%) | 3-100% | 6 | 1 (17%) | 0.4-64% |
Radiation + Hormone therapy | Observation | 24 | 2 (8%) | 1-27% | 55 | 11 (20%) | 10-33% |
Other* | Observation | 1 | 1 (100%) | 3-100% | 6 | 0 (0%) |
In the advjuant setting, ‘other’ treatment recommendations included: “recheck path” and “medical oncologist and radiation oncologist consult”
In the salvage setting ‘other’ treatment recommendations included: “DRE, imaging” x3, “DRE, imaging, possible referral to radiation oncologist” x2, and “referral to medical oncologist”